Last reviewed · How we verify
2% ketoconazole cream
At a glance
| Generic name | 2% ketoconazole cream |
|---|---|
| Sponsor | Chulalongkorn University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Alternation in the Human Microbiome With Commonly Used Topical Medications (PHASE1)
- Comparison of the Efficacy of Topical Luliconazole 2% Cream vs Topical Ketoconazole 1% Cream in the Treatment of Pityriasis Versicolor. (PHASE4)
- Assessment of the Efficacy of Topical Ketoconazole 2% Cream in Comparison With Topical Retinoids in the Treatment of Mild Comedonal and Papulopustular Acne (NA)
- A Therapeutic Equivalence Study of Ketoconazole Cream 2% (PHASE3)
- Non-inferiority Trial of Dapaconazole Versus Ketoconazole (PHASE3)
- Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis (PHASE3)
- Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis (PHASE2)
- The Study of Efficacy and Safety of 2% Ketoconazole Cream in Thai Females With Mild Degree of Post - Adolescence Acne (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 2% ketoconazole cream CI brief — competitive landscape report
- 2% ketoconazole cream updates RSS · CI watch RSS
- Chulalongkorn University portfolio CI